跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Authorized
STANDARD
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7263e8a4f060ba1f
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
7263e8a4f060ba1f
Drug Approval Canada Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Product Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Status
Marketed
Status Date
2021-03-02
Original Market Date
2021-03-02
Din
02496860
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AA09 BENDAMUSTINE
Atc Name
l 01 aa 09
Aig Number
0153268002
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
BENDAMUSTINE HYDROCHLORIDE
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7263e8a4f060ba1f
Type
Standard
Back to Health Canada Approvals